Company news: Johnson & Johnson’s (JNJ) quarterly results beat analysts’ forecasts

Johnson & Johnson (JNJ) reported Q3 FY2024 earnings of $2.42 per share (versus $2.66 per share in Q3 FY2023), strongly beating analysts’ consensus estimate of $2.21 per share.

The company’s quarterly revenues amounted to $22.471 bln (+5.2% y/y), beating analysts’ consensus estimate of $22.172 bln.

The company also issued in-line guidance for FY2024, seeing EPS of $9.88-9.98 versus analysts’ consensus estimate of $9.95 and revenues of $88.4-88.8 bln versus analysts’ consensus estimate of $88.51 bln.

JNJ rose to $162.75 (+0.71%) in pre-market trading.